Nail changes secondary to docetaxel chemotherapy: A case report

Journal of Medical Case Reports

Volumn 2, Issue , 2008, Pages

  Ghafoor, Qamar ^a   Chetiyawardana, Anula ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE;

AGED; ARTICLE; CANCER RELAPSE; CANCER STAGING; CASE REPORT; COUGHING; ERYTHEMA; EXTERNAL BEAM RADIOTHERAPY; HEMOPTYSIS; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; NAIL; NAIL DISEASE; NAIL PIGMENTATION; PRIORITY JOURNAL; SIDE EFFECT;

EID: 45249085956     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-2-24     Document Type: Article

References (5)

1. Docetaxel drug information website http://en.sanofi-aventis.com/group/ products/p_group_products_onco_taxotere.asp
2. Escobar PF Rose PG Docetaxel in ovarian cancer Expert opin pharmacother 2005, 6(15):2719-26. 10.1517/14656566.6.15.2719 16316310
3. Vaishampayan U Parchment RE Jasti BR Hussain M Taxanes: An overview of the pharmacokinetics and pharmacodynamics Urology 1999, 54:22-29. 10.1016/S0090-4295(99)00451-3 10606281
4. Sobin LH Wittekind C International Union against Cancer; TNM: Classification of Malignant Tumors New York, NY: Wiley-Liss 6, 2002.
5. Spazzapon Simon crivellari Diana Lombardi Davide Nail Toxicity related to weekly Taxanes: An important issue requiring a change in Common Toxicity Criteria Grading? J Clin Oncol 2002, 21:4404-4405. 10.1200/ JCO.2002.99.147